Highlights from ACR Convergence 2023
View American College of Rheumatology educational opportunities here - https://rheumatology.org/events-programs
ACR Convergence 2023 Highlights: Obinutuzumab Efficacy and Tolerance in Patients with Autoimmune Diseases Immunized Against Rituximab
By
Highlights from ACR Convergence 2023
FEATURING
Samuel Bitoun
By
Highlights from ACR Convergence 2023
FEATURING
Samuel Bitoun
The above content is not sponsored by, nor part of, the American College of Rheumatology. ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
